— Know what they know.
Not Investment Advice
Also trades as: VEXT.CN (CNQ) · $vol 0M

VEXTF OTC

Vext Science, Inc.
1W: -13.5% 1M: -21.3% 3M: -6.5% YTD: -14.9% 1Y: -41.4% 3Y: -40.4% 5Y: -76.9%
$0.15
-0.00 (-1.26%)
 
Weekly Expected Move ±9.3%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 36 · $37.7M mcap · 248M float · 0.012% daily turnover · Short 33% of daily vol

Income Trends

Revenue
$36M +3.4% ▲
5Y CAGR: +10.0%
Gross Profit
$9M -25.4% ▼
5Y CAGR: -2.3%
Operating Income
-$11M -520.4% ▼
Net Income
-$22M -610.1% ▼
EPS (Diluted)
$-0.09 -448.7% ▼
EBITDA
-$2M -111.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$25M$37M$35M$35M$36M
YoY Growth+12.9%+47.8%-4.9%-1.7%+3.4%
Cost of Revenue$14M$19M$12M$23M$27M
Gross Profit$11M$19M$23M$12M$9M
Gross Margin44.5%50.2%65.2%34.6%24.9%
R&D Expenses$159K$150K$0$0$0
SG&A Expenses$5M$6M$10M$14M$11M
Operating Expenses$8M$9M$14M$14M$20M
Operating Income$3M$9M$9M-$2M-$11M
Operating Margin12.8%25.5%25.2%-5.2%-31.1%
Interest Expense$745K$2M$2M$4M$4M
Income Before Tax$3M$7M$7M$3M-$21M
Tax Expense$514K$2M-$4M-$1M$1M
Net Income$2M$5M$11M$4M-$22M
Net Margin8.4%13.4%30.8%12.6%-62.3%
EPS (Diluted)$0.02$0.03$0.08$0.03$-0.09
EBITDA$6M$13M$15M$17M-$2M
Shares Outstanding94M146M140M165M241M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms